Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses
Silvia Menegatti, Elisabetta Bianchi, Lars Rogge
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
Clara Sophie Bramsen Andersen, Amanda Kvist‐Hansen, Mie Siewertsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6111-6111
Open Access | Times Cited: 23
Biological and clinical significance of T helper 17 cell plasticity
Alessio Mazzoni, Laura Maggi, Francesco Liotta, et al.
Immunology (2019) Vol. 158, Iss. 4, pp. 287-295
Open Access | Times Cited: 48
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu
Life Sciences (2020) Vol. 267, pp. 118923-118923
Open Access | Times Cited: 45
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
Rosa Andres Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
Daniel Ward, Nynne Nyboe Andersen, Sanne Gørtz, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 1, pp. 135-143.e8
Open Access | Times Cited: 13
Colonic strictures in Crohn’s disease: a non-surgical survival
Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, et al.
Future Science OA (2025) Vol. 11, Iss. 1
Open Access
Automated segmentation of the sacro-iliac joints, posterior spinal joints and discovertebral units on low-dose computed tomography for Na[18F]F PET lesion detection in spondyloarthritis patients
Wouter R. P. van der Heijden, Floris H. P. van Velden, Robert Hemke, et al.
EJNMMI Physics (2025) Vol. 12, Iss. 1
Open Access
Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies
Sara Martínez-Ramos, Carlos Rafael‐Vidal, José María Pego‐Reigosa, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 515-515
Open Access | Times Cited: 21
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
Angela Ceribelli, Francesca Motta, Matteo Vecellio, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26
Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm
Jia You, Huawei Li, Peng Fan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
TNFepitope: A webserver for the prediction of TNF-α inducing epitopes
Anjali Dhall, Sumeet Patiyal, Shubham Choudhury, et al.
Computers in Biology and Medicine (2023) Vol. 160, pp. 106929-106929
Closed Access | Times Cited: 10
Treatment overview of axial spondyloarthritis in 2023
Xenofon Baraliakos, Uta Kiltz, Irina Kononenko, et al.
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 3, pp. 101858-101858
Closed Access | Times Cited: 10
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo
Silvia Menegatti, Vincent Guillemot, Eleonora Latis, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 4, pp. 475-486
Open Access | Times Cited: 25
The evaluation of cytokines to help establish diagnosis and guide treatment of autoinflammatory and autoimmune diseases
Anne-Laure Chetaille Nézondet, Patrice E. Poubelle, Martin Pelletier
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 2, pp. 647-657
Open Access | Times Cited: 24
Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?
Stephanie Harrison, Helena Marzo‐Ortega
Current Rheumatology Reports (2023) Vol. 25, Iss. 3, pp. 56-67
Open Access | Times Cited: 7
Temporal dynamics of TNF-mediated changes in hematopoietic stem cell function and recovery
A. Nilsson, Isabel Hidalgo, David Bryder, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106341-106341
Open Access | Times Cited: 7
Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature
Juliëtte Pouw, Emmerik F A Leijten, Timothy R. D. J. Radstake, et al.
Clinical Immunology (2019) Vol. 211, pp. 108318-108318
Open Access | Times Cited: 21
Impact of Home Confinement During the COVID‐19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients
C. Roux, Olivier Brocq, Franck Gérald, et al.
Arthritis & Rheumatology (2020) Vol. 72, Iss. 10, pp. 1771-1772
Open Access | Times Cited: 19
IL-23 in arthritic and inflammatory pain development in mice
Ming-Chin Lee, Zihao Zhang, Adrian Achuthan, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 18
High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
Dong-Hyuk Moon, Aran Kim, Byung-Wook Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 379-379
Open Access | Times Cited: 6
TNF promotes DECTIN2 family C-type lectin receptor expression in human macrophages
Carl Haberkamp, Ida Allabauer, Niklas Blaha, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 6, pp. 615-625
Closed Access | Times Cited: 6
Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis
Eleni Christodoulou‐Vafeiadou, Christina Geka, Lydia Ntari, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 17
A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
Hisashi Yamanaka, Naoyuki Kamatani, Yoshiya Tanaka, et al.
Rheumatology and Therapy (2019) Vol. 7, Iss. 1, pp. 149-163
Open Access | Times Cited: 17
CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
Rarastoeti Pratiwi, Nyoman Yudi Antara, Lalu Gunawan Fadliansyah, et al.
F1000Research (2019) Vol. 8, pp. 1770-1770
Open Access | Times Cited: 14
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)
Ana‐Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, et al.
Rheumatology and Therapy (2020) Vol. 8, Iss. 1, pp. 199-217
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top